// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "EW JA cleavage agent details VK TMT SH CPTAC ENVO TO AC HF XL SRM MS QY REQUIRES HANCESTRO NCIT:C25683 organism part PO fraction identifier EBI SP ANY DIA STANDARDS LIMITED ISA INITIATIVE age fractionation method WILL exclamation FDR biosample accession number RIGHTS CV EM III NCIT:C25714 REQUIRED SDRF MS:1001251 IS INCLUDING ROW II alkylation reagent MAY MS:1000484 BRENDA CN CELL ALL data file spiked compound OF PS EXPRESS PRIDE:0000590 MOD MIAME PRIDE:0000833 HUPO ancestry category IMPLIED UBERON developmental stage URI MONDO HLA THAT RECOMMENDED RAW OR CS NCIT HEREIN RECOMMEND BE proteomics data acquisition method LC RFC not TA PP sex NCBI FOR CID PATO:0000461 PROTEOMICS SILAC TAB BMC IMPORTANT MAGE PRIDE:0000832 NCI ID CT MAJOR MERCHANTABILITY DDA PTM IDF EFO THE INFORMATION source name sample PMCID PSI NT DTT collision energy CF pooled sample IAA FAIR HCD cell type VCF SWATH SHOULD BTO XML NOT disease URL USE YAML SAMN HTML PURPOSE mass MT WARRANTIES PRIDE AS MIAPE FITNESS ... PARTICULAR BUT characteristics instrument INFRINGE PRIDE:0000834 NCE DJ SHALL depletion individual PATCH MC PMID TIP MUST README PRIDE:0000659 PRIDE:0000831 label reduction reagent ZFA CL COLUMN CLO LI file your PEPTIDESEQ DISCLAIMS NOTE COULD biological replicate AND technical replicate SN PRM WARRANTY SAMEA MHC PATO dissociation method MINOR organism OPTIONAL"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "EW JA cleavage agent details VK TMT SH CPTAC ENVO TO AC HF XL SRM MS QY REQUIRES HANCESTRO NCIT:C25683 organism part PO fraction identifier EBI SP ANY DIA STANDARDS LIMITED ISA INITIATIVE age fractionation method WILL FDR biosample accession number RIGHTS CV EM III NCIT:C25714 REQUIRED SDRF MS:1001251 IS INCLUDING ROW II alkylation reagent MAY MS:1000484 BRENDA CN CELL ALL data file spiked compound OF PS EXPRESS PRIDE:0000590 MOD MIAME PRIDE:0000833 HUPO IMPLIED UBERON URI MONDO HLA THAT RECOMMENDED RAW OR CS NCIT HEREIN RECOMMEND BE proteomics data acquisition method LC RFC TA PP NCBI FOR CID PATO:0000461 PROTEOMICS SILAC TAB BMC MAGE PRIDE:0000832 NCI CT MAJOR MERCHANTABILITY DDA PTM IDF EFO THE INFORMATION PMCID PSI NT DTT collision energy CF pooled sample IAA FAIR HCD cell type VCF SWATH SHOULD BTO NOT disease URL USE YAML SAMN HTML PURPOSE mass MT WARRANTIES PRIDE AS MIAPE FITNESS ... PARTICULAR BUT instrument INFRINGE PRIDE:0000834 NCE DJ SHALL depletion individual PATCH MC PMID MUST README PRIDE:0000659 PRIDE:0000831 label reduction reagent ZFA CL COLUMN CLO LI PEPTIDESEQ DISCLAIMS technical replicate COULD biological replicate AND SN PRM WARRANTY SAMEA MHC PATO dissociation method MINOR organism OPTIONAL"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "synthetic peptide xenograft MONDO:0004989 MAY CL:0000066 enrichment process CL:0000084 ID developmental stage UBERON MONDO CL:0000624 depletion PTM EFO MONDO:0005148 UBERON:0000178 organism part PO MUST DOID CL:0000815 PATO:0001421 cell type CL age exclamation disease NOTE PDX NCBI UBERON:0002107 SDRF PATO PATO:0000461 APP organism MONDO:0004975"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "synthetic peptide xenograft MONDO:0004989 MAY CL:0000066 enrichment process CL:0000084 ID developmental stage UBERON MONDO CL:0000624 depletion PTM EFO MONDO:0005148 UBERON:0000178 organism part PO MUST DOID CL:0000815 PATO:0001421 cell type CL age disease PDX NCBI UBERON:0002107 SDRF PATO PATO:0000461 APP organism MONDO:0004975"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C28078 treatment response NCIT:C15262 TNM staging NCIT:C28076 NCIT:C71732 Dukes stage NCIT:C4870 ER AJCC MONDO:0005044 GDPR menopausal status CHEBI:27899 CHEBI:28748 IMPORTANT sampling time point NCI ID ancestry category MONDO dose HANCESTRO individual NCIT:C65106 MONDO:0005148 pre-existing condition organism part PR NCIT:C18206 disease stage smoking status tumor grade treatment NCIT IV NCIT:C27971 NCIT:C65107 weight HANCESTRO:0005 NCIT:C53554 breast cancer subtype compound exclamation NCIT:C15632 HANCESTRO:0009 body mass index NCIT:C65108 treatment status HIPAA SDRF NCIT:C27966 TNM Ann Arbor stage"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C28078 treatment response NCIT:C15262 TNM staging NCIT:C28076 NCIT:C71732 Dukes stage NCIT:C4870 ER AJCC MONDO:0005044 GDPR menopausal status CHEBI:27899 CHEBI:28748 sampling time point NCI ID ancestry category MONDO dose HANCESTRO individual NCIT:C65106 MONDO:0005148 pre-existing condition organism part PR NCIT:C18206 disease stage smoking status tumor grade treatment NCIT IV NCIT:C27971 NCIT:C65107 weight HANCESTRO:0005 NCIT:C53554 breast cancer subtype compound NCIT:C15632 HANCESTRO:0009 body mass index NCIT:C65108 treatment status HIPAA SDRF NCIT:C27966 TNM Ann Arbor stage"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "cleavage agent details PRIDE SILAC TMT PRIDE:0000564 AC HF MS1 scan range PRIDE:0000590 MOD MS PSI NT README PRIDE:0000285 HCD label MS:1001309 DIA UNIMOD fragment mass tolerance precursor mass tolerance scan window lower limit exclamation MS2 analyzer type NOTE TA UNIMOD:4 PP CV scan window upper limit UNIMOD:35 SDRF MS:1002523 REQUIRED MS:1001251 modification parameters MT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "cleavage agent details PRIDE SILAC TMT PRIDE:0000564 AC HF MS1 scan range PRIDE:0000590 MOD MS PSI NT PRIDE:0000285 HCD label MS:1001309 DIA UNIMOD fragment mass tolerance precursor mass tolerance scan window lower limit MS2 analyzer type TA UNIMOD:4 PP CV scan window upper limit UNIMOD:35 SDRF MS:1002523 REQUIRED MS:1001251 modification parameters MT"
  }
];
